Management of Type 2 Diabetes Mellitus and Cardiovascular Risk
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 60 (5) , 975-983
- https://doi.org/10.2165/00003495-200060050-00001
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Insulin resistance and thrombosis: a cardiologist’s viewThe American Journal of Cardiology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 DiabetesDiabetes Care, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDMDiabetes Care, 1993
- Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complicationsJournal Of Hypertension, 1993
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987